The Jersey government should support doctors on the island to prescribe medical cannabis, a member of the States Assembly of Jersey has said.
Pharmacists should be more involved in managing prescription-only medicine dependency, Welsh Assembly says
NHS Wales should make better use of pharmacists’ expertise in supporting patients who become dependent on prescription medicines, a committee that advises the Welsh Assembly has said.
The number of people using crack cocaine has increased by 8.5% in the past five years, according to the latest data from a Home Office and Public Health England investigation.
Over 3,000 more pharmacists needed in general practice to tackle GP shortages, says think tank report
A minimum of 3,000 extra pharmacists are needed in general practice across England by 2024 to help tackle rising patient demand and GP shortages, a report compiled by three major think-tanks warns.
Universities could drop MPharm programmes if student placements are not funded under GPhC education proposals
Universities may drop MPharm from their undergraduate programme if they are expected to pick up the bill for student placements as part of five-year integrated degrees, the head of the Pharmacy Schools Council has warned.
Generics manufacturers across the EU have spent €700m on implementing the Falsified Medicines Directive, the British Generics Manufacturers Association has estimated.
Guidance for the prescription of medical cannabis has been issued by the by the Medical Cannabis Clinicians’ Society and the All-Party Parliamentary Group for Medical Cannabis under Prescription.
Pharmacy minister Steve Brine resigned from the government to support a move that gives MPs the chance to consider which form of Brexit they would support.
Non-NHS organisations, including charities and local authorities, have had to pay £5.6m for drugs under the generics price concessions scheme in 2018, data analysts have found.
Commissioners must recognise “the value of pharmacy” in order to provide better sexual health services to patients, Public Health England has said.
NHS England has told pharmacy providers that the NHS Urgent Medicine Supply Advanced Service (NUMSAS) pilot is to be extended for another six months, until 30 September 2019.
It is unlikely that figures on NHS England prescriptions for medical cannabis will be published by the end of March 2019, despite ministerial assurances that they would, Jizak has been told.
Insulin suppliers have increased their UK stocks to include 16 weeks’ worth of extra supplies as part of their no-deal Brexit planning.
New standards for pharmacy education and training could have a “negative impact” on recruitment of pharmacy students, Community Pharmacy Scotland has said.
Delaying or withholding antibiotics in older adults with urinary tract infections is associated with an increased risk of bloodstream infection and all-cause mortality, research published in The BMJ has shown.
Compared with patients taking warfarin monotherapy, those taking aspirin and warfarin were at a higher risk of a bleeding event but the rate of thrombotic events was similar.
Early intensive therapy may delay MS progressionSubscription
Early aggressive therapy for multiple sclerosis is associated with improved long-term outcomes compared with an escalation approach, a study in JAMA Neurology has shown.
Women with high-risk human papillomavirus infection are more likely to develop cardiovascular disease than those without, the results of a study published in Circulation Research suggest.
The rate of falls in older adults living in the community can be effectively reduced with exercise interventions, the authors of a recent Cochrane review have concluded.
Direct acting, rather than prodrug, opioids should be considered for postoperative pain relief in patients with depression receiving selective serotonin reuptake inhibitors, researchers have found.
Enzyme mouth spray could shorten cold durationSubscription
An oral spray containing a proteolytic enzyme reduced the severity and duration of the common cold, a randomised study has found.
Study shows needle and syringe programmes reduce transmission of hepatitis C while delivering cost savings.